HHC Changzhou Corp. (301061) fair value: what the stock is really worth
As of Oct 16, 2026: fair value (intrinsic value) of HHC Changzhou Corp. stock ¥56.02, price ¥36.40, upside +53.9%, quality 68 out of 100. Rating: strongly undervalued. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Oct 2, 2026.
How to read this chart
60‑month range ¥11.53 – ¥90.15 · fair‑value band ¥35.63 – ¥94.22 · the ¥36.40 price screens below the ¥56.02 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Oct 2, 2026.
Follow HHC Changzhou in your weekly email
Every Wednesday you see whether HHC Changzhou is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
MotoMotion China Corporation engages in the research, design, development, production, sales, and service of smart electric sofas, smart electric beds, and its accessories in China and internationally. It sells its products under the MotoMotion, MotoLiving, MotoSleep, and MotoTec brands.
Show moreShow less
The company was founded in 2002 and is headquartered in Changzhou, the People's Republic of China.
Stock analysis
HHC Changzhou Corp. (301061) currently trades at ¥36.40, while our model-based Fair Value estimate is ¥56.02, implying the stock looks roughly 35.0% undervalued today.
Show more
Valuation
Bull case: the Growth Earnings group reads highest at a median of ¥103.00 per share, and 18 of the 26 models we run sit above the ¥36.40 price.
Bear case: the Dividend Discount group reads lowest at ¥9.35, and 8 of the 26 models stay below the price. Data coverage for this calculation is high.
Scenario range: ¥35.63 (bear) to ¥94.22 (bull), the price of ¥36.40 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 68/100 (solid quality), in the Consumer Cyclical sector.
Healthy Growth: Revenue growth appears healthy and is supported by profitability and cash-flow quality.
HHC Changzhou Corp. reported revenue of 3.4B CNY in FY2025 versus 1.9B CNY in FY2021, a compound +15.1%/yr. Reported net income was 857M CNY in FY2025, compounding +30.2%/yr from FY2021.
Key figures
Market cap 10.4B CNY (≈ $1.5B) Small · P/E ratio 14.2 · P/S ratio 3.17 · EPS (TTM) ¥2.56 · Dividend yield 2.4% · Net margin 22.5% · Return on equity 17.7% · Return on assets (EBIT) 13.1%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 80 out of 100 (low confidence).
What moves the price
The share trades about 57% below its 52-week high and 12% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Consumer Cyclical peers we cover trades at 22% fair-value upside, at 54%, 301061 screens cheaper than that median.
Fair Value models
Bear¥35.63Fair Value ¥56.02Bull¥94.22
Price ¥36.40 · Upside +53.9%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 10 months old). Earnings retained since then (¥1.34 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
FCF DCF¥44.19¥61.85¥115.3276
Growth DCF¥41.92¥65.90¥110.8574
Residual Income¥17.76¥24.27¥42.7873
All 26 models by family
DCF Models
FCF DCF¥44.19¥61.85¥115.3276
Owner Earnings¥37.91¥71.52¥135.7570
5Y Revenue Exit¥26.69¥36.38¥56.3470
5Y EBITDA Exit¥42.49¥68.31¥118.9070
5Y P/E Exit¥54.36¥113.66¥194.7965
10Y Revenue Exit¥32.13¥51.67¥61.2965
10Y EBITDA Exit¥43.34¥83.53¥152.6463
10Y P/E Exit¥51.47¥107.46¥200.1258
Earnings-Based
Graham-Dodd¥20.50¥142.98¥200.6563
Lynch FV¥55.99¥79.99¥103.9961
PEG = 1.0¥55.99¥79.99¥103.9957
EPV¥30.29¥33.50¥36.2168
Dividend Discount
Gordon GGM¥5.59¥10.43¥14.8167
DDM Multi-Stage¥5.59¥9.35¥11.1067
Multiples
P/E Multiple¥49.75¥66.33¥82.9163
P/S Multiple¥10.69¥14.26¥17.8258
P/B Multiple¥44.22¥58.96¥73.7055
EV/EBIT¥53.44¥68.60¥83.7663
EV/EBITDA¥40.97¥51.97¥62.9764
EV/Revenue¥17.95¥22.23¥26.5152
Asset-Based
NCAV (Graham)¥8.76¥13.28¥16.6052
Growth DCF
Growth DCF¥41.92¥65.90¥110.8574
Rev-Margin DCF¥27.00¥40.52¥66.2069
Economic Profit
Residual Income¥17.76¥24.27¥42.7873
ROIC Compounder¥35.52¥45.98¥59.4570
Growth Earnings
Growth-Adj P/E¥72.10¥103.00¥133.9067
The fair value above starts from this blend and is adjusted for dilution from new shares.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.100/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Revenue growth 1 year
+32.6%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+32.2%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+20.7%
Start year 2020 (pandemic)
Revenue growth 6 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+19.3%
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years) (mathematically smoothed) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Smoothed = median of all growth paths between the years of the window (trend line on the logarithm of earnings per share): a single extreme year cannot distort the rate. The reported figure stays in the tooltip.
+24.2%
Earnings growth per share plus dividend.
Earnings per share, growth per year+21.8%
Dividend (yield on the price)2.4%
Profit margin 2019 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.10% → 28%
2025 sits 171% above its own trend. The rate follows the median trend of the last 5 years, not that single year.
Growth Forecast
Little optimism in the price
The price assumes less growth than the company has delivered so far and less than analysts expect.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
−4.5%
The company could shrink this much every year for the next five years and today's price would still be justified.
What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.
+13.9%
Yearly sales growth analysts expect, extended to five years.
After inflation (China: IMF forecast 1.7% a year to 2030, 1.4% from 2016 to 2025) that is about −6.1% a year for the price and +12.1% for the forecasts.
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Furnishings, Fixtures & Appliances · 302 stocks
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Is HHC Changzhou Corp. (301061) overvalued or undervalued?
As of Oct 2, 2026, our model estimates a fair value of ¥56.02 versus a price of ¥36.40, about +54% upside (undervalued).
What is the fair value of 301061?
Our model-based fair value for HHC Changzhou Corp. is ¥56.02 (as of Oct 2, 2026), built from audited fundamentals. The current price: ¥36.40.
What is the quality score of 301061?
HHC Changzhou Corp. has a Quality Score of 68/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for HHC Changzhou Corp. (301061)?
Our model-based price target is the fair value of ¥56.02 (as of Oct 2, 2026) from 26 valuation models. Cautious scenario ¥35.63, optimistic scenario ¥94.22. It is a calculation from audited fundamentals, not an analyst target.
What is the HHC Changzhou Corp. stock forecast for 2026?
Our models put fair value at ¥56.02, about +54% upside versus a price of ¥36.40 (undervalued). Cautious scenario ¥35.63, optimistic scenario ¥94.22. The calculation is refreshed regularly with new filings.
What is the revenue of HHC Changzhou Corp. (301061)?
HHC Changzhou Corp. reported trailing-twelve-month revenue of about 3.3B CNY (latest available figure, as of Oct 2, 2026).
Does HHC Changzhou Corp. pay a dividend?
HHC Changzhou Corp. currently shows a dividend yield of 2.43% relative to its recent price (as of Oct 2, 2026).
What growth is priced into HHC Changzhou Corp. (301061)?
For today's price to be fair in a discounted-cash-flow model, HHC Changzhou Corp. would have to grow free cash flow by -4.5 % per year for five years (discount rate 10.4 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +20.7 % per year. As of Oct 2, 2026.
What discount rate (WACC) does the fair value of 301061 use?
Our models discount HHC Changzhou Corp. at 10.4 %: a base by market capitalisation (small), damped by beta 0.29, country premium for China. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For HHC Changzhou Corp. that is -4.5 % per year a year over ten years, using the same discount rate (10.4 %) and the same formula as our fair value.
How much growth has HHC Changzhou Corp. (301061) delivered so far?
Over the past 5 years revenue at HHC Changzhou Corp. grew +20.7 % a year. The price currently implies -4.5 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of HHC Changzhou Corp. (301061) growing?
The median revenue growth in the sector is +4.3 % a year. That is the yardstick for the growth priced into HHC Changzhou Corp. (-4.5 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of HHC Changzhou Corp. (301061)?
The free-cash-flow yield on the price is 8.85 %: that much free cash flow HHC Changzhou Corp. produces per unit of market value. When it exceeds the discount rate of our models (10.4 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of HHC Changzhou Corp. (301061)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For HHC Changzhou Corp. it is ¥56.02 per share (as of Oct 2, 2026), against a price of ¥36.40. It is the blended result of 26 valuation models (cash flow, earnings, asset, dividend).
Is HHC Changzhou Corp. stock overvalued or undervalued in 2026?
As of Oct 2, 2026, 301061 trades below its calculated fair value: price ¥36.40, fair value ¥56.02, a gap of about +54% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 301061?
No. The price is what the market pays today (¥36.40); the fair value is what the company's own numbers justify (¥56.02). For HHC Changzhou Corp. the two are ¥19.62 per share apart. That gap is exactly why we show both numbers side by side.
How much is HHC Changzhou Corp. worth?
The market values HHC Changzhou Corp. at about 10.4B CNY (market capitalisation, as of Oct 2, 2026). Per share that is ¥36.40; our models calculate a fair value of ¥56.02 per share.
What do the bullish and bearish scenarios say about 301061?
Our models span a range for HHC Changzhou Corp.: cautious scenario ¥35.63, base ¥56.02, optimistic ¥94.22 per share (as of Oct 2, 2026, price ¥36.40). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 301061?
HHC Changzhou Corp. trades at a price-to-earnings ratio of 14.2 (as of Oct 2, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of ¥56.02 is built from several models across several years. Other multiples: P/B 2.5, P/S 3.2, EV/EBITDA 9.0.
How solid is the balance sheet of HHC Changzhou Corp. (301061)?
Balance-sheet figures for HHC Changzhou Corp. (as of Oct 2, 2026): return on equity 17.7%. They feed the Quality Score of 68/100, which measures business quality independently of the share price.
How far is 301061 from its 52-week high?
HHC Changzhou Corp. trades at ¥36.40, about 57% below its 52-week high of ¥84.56 and 12% above the low of ¥32.60 (as of Oct 16, 2026). Distance from the high says nothing about value: that is what the fair value of ¥56.02 is for.
Which stocks are comparable to HHC Changzhou Corp.?
From the same area (Consumer Cyclical) we also value Midea Group, King Slide Works Co, Gree Electric Appliances, Inc, Haier Smart Home Co, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is HHC Changzhou Corp. stock attractive at the current price?
The data as of Oct 2, 2026: price ¥36.40, calculated fair value ¥56.02 (+54%), Quality Score 68/100, from 26 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 301061 calculated?
We run HHC Changzhou Corp. through 26 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of ¥56.02, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.8 % above its aggregate fair value. HHC Changzhou Corp. currently trades 35 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of HHC Changzhou Corp. (301061)?
The closing price on Oct 16, 2026 was ¥36.40. Our model-based fair value is ¥56.02, about +54% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with HHC Changzhou Corp. right now?
The model range is unusually wide (¥35.63 to ¥94.22). The outcome hinges heavily on assumptions, so read the point estimate with caution. Solid quality (68/100) at a price below fair value, the discount is the argument here, not the business quality.
Key figures of HHC Changzhou Corp.
How large is the market capitalisation of HHC Changzhou Corp. (301061)?
The market capitalisation of HHC Changzhou Corp. is 10.4B CNY (≈ $1.5B). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of HHC Changzhou Corp. (301061)?
The price-to-sales ratio of HHC Changzhou Corp. is 3.17 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of HHC Changzhou Corp. (301061)?
Earnings per share at HHC Changzhou Corp. are ¥2.56 (price ÷ EPS = P/E 14.2). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of HHC Changzhou Corp. (301061)?
The dividend yield of HHC Changzhou Corp. is 2.4% (payout 34.6%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of HHC Changzhou Corp. (301061)?
The net margin of HHC Changzhou Corp. is 22.5% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of HHC Changzhou Corp. (301061)?
The return on equity (ROE) of HHC Changzhou Corp. is 17.7% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of HHC Changzhou Corp. (301061)?
On an EBIT basis the return on assets of HHC Changzhou Corp. is 13.1% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of HHC Changzhou Corp. (301061)?
The operating margin of HHC Changzhou Corp. is 26.3% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at HHC Changzhou Corp. (301061)?
Revenue at HHC Changzhou Corp. is growing −9.8% versus a year earlier (3y avg +32.2%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at HHC Changzhou Corp. (301061)?
Earnings per share at HHC Changzhou Corp. are growing −41.1% versus a year earlier. How much earnings per share grew versus a year earlier.
Free · no account needed
Watch HHC Changzhou Corp. in the live analysis
One click puts HHC Changzhou Corp. on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 28,000+ stock screener.
Broad data
Oct 2, 2026